UNSPSC 51312900: Antihistamine or H1 blocker phenanthrolines

Antihistamine or H1 blocker drugs made from 1,10-phenanthroline.

UNSPSC 51312900 Antihistamine or H1 blocker phenanthrolines is a Class code that in practice captures pharmaceutical products and drug-management systems procured by state and local health agencies. Recent solicitations under this code show state and local buyers acquiring naloxone—an opioid antagonist used in overdose response—alongside drug deactivation and disposal systems to support community health and harm-reduction initiatives. Seminole County, Florida has been an active issuer in this space, soliciting through competitive bidding processes (IFB format) to acquire pharmaceutical inventory on recurring annual contracts with renewal options. The work involves not only product procurement but also compliance with federal funding requirements, insurance standards, E-Verify employment verification, and drug-free workplace certification.

Seminole County, Florida represents the geographic concentration visible in recent activity under this code. The county posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The contract structure includes a two-year initial term with one-year renewal option, fixed-fee pricing, a three-month probationary termination window, and potential FEMA funding with attendant federal compliance obligations. Vendors must absorb all shipping and delivery costs and meet standard commercial insurance, workers' compensation, and professional liability requirements. The source provides no evidence of recent opportunities outside Florida or from issuing bodies other than Seminole County.